Quarterly report pursuant to Section 13 or 15(d)

Restructuring (Details Narrative)

Restructuring (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jan. 31, 2023
Jun. 30, 2023
Jun. 30, 2023
Restructuring Cost and Reserve [Line Items]      
Restructuring description the Company commenced a strategic restructuring program aimed at capital preservation. In April 2023, the Company approved the implementation of additional cost cutting measures, including an executive reorganization and other cuts in clinical expenses, in connection with its ongoing efforts to reduce operating expenses. In addition, the non-management members of the Board agreed to defer their Board fees until a future date    
Restructuring charges   $ 94  
Payments for restructuring   416 $ 1,423 [1]
Strategic Restructuring Program [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges   $ 267 $ 1,517
[1] Employee severance and other benefits expenses were included in sales and marketing expenses, research and development expenses, and general and administrative expenses in the statements of comprehensive loss.